The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Insulin API-Global Market Insights and Sales Trends 2025
Synopsis
Insulin is used to treat type 1 diabetes (condition in which the body does not produce insulin and therefore cannot control the amount of sugar in the blood). It is also used to treat people with type 2 diabetes (condition in which the body does not use insulin normally and, therefore, cannot control the amount of sugar in blood) who need insulin to control their diabetes. Nowadays, Insulin as an important drug is widely used to treat diabetes.
In China and Chinese insulin market, animal insulin, called first generation insulin, has been almost replaced by new type generation insulin. Basing on the trend of China and Chinese insulin industry, this report researches the market of human insulin and insulin analogue in China.
In this report, the statistics of insulin industry is based on Insulin API, the physical features of insulin API is Freeze-dried powder. The weight unite of insulin API weight is Kg in this report.
The global Insulin API market size is expected to reach US$ 2137.4 million by 2029, growing at a CAGR of 2.9% from 2023 to 2029. The market is mainly driven by the significant applications of Insulin API in various end use industries. The expanding demands from the Fast-Acting, Premix and Long-Acting,, are propelling Insulin API market. Regular Human Insulin, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Insulin Analogue segment is estimated at % CAGR for the next seven-year period.
The major players in global Insulin API market include Novo Nordisk, Sanofi-Aventis, etc. The top 2 players occupy over 65% shares of the global market. North America and Europe are main markets, they occupy about 70% of the global market. Insulin Analogue is the main market, and occupies about 90% of the global market. Long-Acting is the main type, with a share over 40%.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Insulin API, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Insulin API market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Insulin API market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Insulin API sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Insulin API covered in this report include Novo Nordisk, Sanofi-Aventis, Eli Lilly, Tonghua Dongbao, Ganlee, United Laboratory, Biocon, Amphastar and Wockhardt, etc.
The global Insulin API market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Novo Nordisk
Sanofi-Aventis
Eli Lilly
Tonghua Dongbao
Ganlee
United Laboratory
Biocon
Amphastar
Wockhardt
Julphar Diabetes
Torrent Pharma
Global Insulin API market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Insulin API market, Segment by Type:
Regular Human Insulin
Insulin Analogue
Global Insulin API market, by Application
Fast-Acting
Premix
Long-Acting
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Insulin API manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Insulin API in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Insulin is used to treat type 1 diabetes (condition in which the body does not produce insulin and therefore cannot control the amount of sugar in the blood). It is also used to treat people with type 2 diabetes (condition in which the body does not use insulin normally and, therefore, cannot control the amount of sugar in blood) who need insulin to control their diabetes. Nowadays, Insulin as an important drug is widely used to treat diabetes.
In China and Chinese insulin market, animal insulin, called first generation insulin, has been almost replaced by new type generation insulin. Basing on the trend of China and Chinese insulin industry, this report researches the market of human insulin and insulin analogue in China.
In this report, the statistics of insulin industry is based on Insulin API, the physical features of insulin API is Freeze-dried powder. The weight unite of insulin API weight is Kg in this report.
The global Insulin API market size is expected to reach US$ 2137.4 million by 2029, growing at a CAGR of 2.9% from 2023 to 2029. The market is mainly driven by the significant applications of Insulin API in various end use industries. The expanding demands from the Fast-Acting, Premix and Long-Acting,, are propelling Insulin API market. Regular Human Insulin, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Insulin Analogue segment is estimated at % CAGR for the next seven-year period.
The major players in global Insulin API market include Novo Nordisk, Sanofi-Aventis, etc. The top 2 players occupy over 65% shares of the global market. North America and Europe are main markets, they occupy about 70% of the global market. Insulin Analogue is the main market, and occupies about 90% of the global market. Long-Acting is the main type, with a share over 40%.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Insulin API, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Insulin API market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Insulin API market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Insulin API sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Insulin API covered in this report include Novo Nordisk, Sanofi-Aventis, Eli Lilly, Tonghua Dongbao, Ganlee, United Laboratory, Biocon, Amphastar and Wockhardt, etc.
The global Insulin API market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Novo Nordisk
Sanofi-Aventis
Eli Lilly
Tonghua Dongbao
Ganlee
United Laboratory
Biocon
Amphastar
Wockhardt
Julphar Diabetes
Torrent Pharma
Global Insulin API market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Insulin API market, Segment by Type:
Regular Human Insulin
Insulin Analogue
Global Insulin API market, by Application
Fast-Acting
Premix
Long-Acting
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Insulin API manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Insulin API in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Insulin API Market Overview
1.1 Insulin API Product Overview
1.2 Insulin API Market Segment by Type
1.2.1 Regular Human Insulin
1.2.2 Insulin Analogue
1.3 Global Insulin API Market Size by Type
1.3.1 Global Insulin API Market Size Overview by Type (2018-2029)
1.3.2 Global Insulin API Historic Market Size Review by Type (2018-2023)
1.3.3 Global Insulin API Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Insulin API Sales Breakdown by Type (2018-2023)
1.4.2 Europe Insulin API Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Insulin API Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Insulin API Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Insulin API Sales Breakdown by Type (2018-2023)
2 Global Insulin API Market Competition by Company
2.1 Global Top Players by Insulin API Sales (2018-2023)
2.2 Global Top Players by Insulin API Revenue (2018-2023)
2.3 Global Top Players by Insulin API Price (2018-2023)
2.4 Global Top Manufacturers Insulin API Manufacturing Base Distribution, Sales Area, Product Type
2.5 Insulin API Market Competitive Situation and Trends
2.5.1 Insulin API Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Insulin API Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Insulin API as of 2022)
2.7 Date of Key Manufacturers Enter into Insulin API Market
2.8 Key Manufacturers Insulin API Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Insulin API Status and Outlook by Region
3.1 Global Insulin API Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Insulin API Historic Market Size by Region
3.2.1 Global Insulin API Sales in Volume by Region (2018-2023)
3.2.2 Global Insulin API Sales in Value by Region (2018-2023)
3.2.3 Global Insulin API Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Insulin API Forecasted Market Size by Region
3.3.1 Global Insulin API Sales in Volume by Region (2024-2029)
3.3.2 Global Insulin API Sales in Value by Region (2024-2029)
3.3.3 Global Insulin API Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Insulin API by Application
4.1 Insulin API Market Segment by Application
4.1.1 Fast-Acting
4.1.2 Premix
4.1.3 Long-Acting
4.2 Global Insulin API Market Size by Application
4.2.1 Global Insulin API Market Size Overview by Application (2018-2029)
4.2.2 Global Insulin API Historic Market Size Review by Application (2018-2023)
4.2.3 Global Insulin API Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Insulin API Sales Breakdown by Application (2018-2023)
4.3.2 Europe Insulin API Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Insulin API Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Insulin API Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Insulin API Sales Breakdown by Application (2018-2023)
5 North America Insulin API by Country
5.1 North America Insulin API Historic Market Size by Country
5.1.1 North America Insulin API Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Insulin API Sales in Volume by Country (2018-2023)
5.1.3 North America Insulin API Sales in Value by Country (2018-2023)
5.2 North America Insulin API Forecasted Market Size by Country
5.2.1 North America Insulin API Sales in Volume by Country (2024-2029)
5.2.2 North America Insulin API Sales in Value by Country (2024-2029)
6 Europe Insulin API by Country
6.1 Europe Insulin API Historic Market Size by Country
6.1.1 Europe Insulin API Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Insulin API Sales in Volume by Country (2018-2023)
6.1.3 Europe Insulin API Sales in Value by Country (2018-2023)
6.2 Europe Insulin API Forecasted Market Size by Country
6.2.1 Europe Insulin API Sales in Volume by Country (2024-2029)
6.2.2 Europe Insulin API Sales in Value by Country (2024-2029)
7 Asia-Pacific Insulin API by Region
7.1 Asia-Pacific Insulin API Historic Market Size by Region
7.1.1 Asia-Pacific Insulin API Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Insulin API Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Insulin API Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Insulin API Forecasted Market Size by Region
7.2.1 Asia-Pacific Insulin API Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Insulin API Sales in Value by Region (2024-2029)
8 Latin America Insulin API by Country
8.1 Latin America Insulin API Historic Market Size by Country
8.1.1 Latin America Insulin API Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Insulin API Sales in Volume by Country (2018-2023)
8.1.3 Latin America Insulin API Sales in Value by Country (2018-2023)
8.2 Latin America Insulin API Forecasted Market Size by Country
8.2.1 Latin America Insulin API Sales in Volume by Country (2024-2029)
8.2.2 Latin America Insulin API Sales in Value by Country (2024-2029)
9 Middle East and Africa Insulin API by Country
9.1 Middle East and Africa Insulin API Historic Market Size by Country
9.1.1 Middle East and Africa Insulin API Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Insulin API Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Insulin API Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Insulin API Forecasted Market Size by Country
9.2.1 Middle East and Africa Insulin API Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Insulin API Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Novo Nordisk
10.1.1 Novo Nordisk Company Information
10.1.2 Novo Nordisk Introduction and Business Overview
10.1.3 Novo Nordisk Insulin API Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Novo Nordisk Insulin API Products Offered
10.1.5 Novo Nordisk Recent Development
10.2 Sanofi-Aventis
10.2.1 Sanofi-Aventis Company Information
10.2.2 Sanofi-Aventis Introduction and Business Overview
10.2.3 Sanofi-Aventis Insulin API Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Sanofi-Aventis Insulin API Products Offered
10.2.5 Sanofi-Aventis Recent Development
10.3 Eli Lilly
10.3.1 Eli Lilly Company Information
10.3.2 Eli Lilly Introduction and Business Overview
10.3.3 Eli Lilly Insulin API Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Eli Lilly Insulin API Products Offered
10.3.5 Eli Lilly Recent Development
10.4 Tonghua Dongbao
10.4.1 Tonghua Dongbao Company Information
10.4.2 Tonghua Dongbao Introduction and Business Overview
10.4.3 Tonghua Dongbao Insulin API Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Tonghua Dongbao Insulin API Products Offered
10.4.5 Tonghua Dongbao Recent Development
10.5 Ganlee
10.5.1 Ganlee Company Information
10.5.2 Ganlee Introduction and Business Overview
10.5.3 Ganlee Insulin API Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Ganlee Insulin API Products Offered
10.5.5 Ganlee Recent Development
10.6 United Laboratory
10.6.1 United Laboratory Company Information
10.6.2 United Laboratory Introduction and Business Overview
10.6.3 United Laboratory Insulin API Sales, Revenue and Gross Margin (2018-2023)
10.6.4 United Laboratory Insulin API Products Offered
10.6.5 United Laboratory Recent Development
10.7 Biocon
10.7.1 Biocon Company Information
10.7.2 Biocon Introduction and Business Overview
10.7.3 Biocon Insulin API Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Biocon Insulin API Products Offered
10.7.5 Biocon Recent Development
10.8 Amphastar
10.8.1 Amphastar Company Information
10.8.2 Amphastar Introduction and Business Overview
10.8.3 Amphastar Insulin API Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Amphastar Insulin API Products Offered
10.8.5 Amphastar Recent Development
10.9 Wockhardt
10.9.1 Wockhardt Company Information
10.9.2 Wockhardt Introduction and Business Overview
10.9.3 Wockhardt Insulin API Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Wockhardt Insulin API Products Offered
10.9.5 Wockhardt Recent Development
10.10 Julphar Diabetes
10.10.1 Julphar Diabetes Company Information
10.10.2 Julphar Diabetes Introduction and Business Overview
10.10.3 Julphar Diabetes Insulin API Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Julphar Diabetes Insulin API Products Offered
10.10.5 Julphar Diabetes Recent Development
10.11 Torrent Pharma
10.11.1 Torrent Pharma Company Information
10.11.2 Torrent Pharma Introduction and Business Overview
10.11.3 Torrent Pharma Insulin API Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Torrent Pharma Insulin API Products Offered
10.11.5 Torrent Pharma Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Insulin API Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Insulin API Industrial Chain Analysis
11.4 Insulin API Market Dynamics
11.4.1 Insulin API Industry Trends
11.4.2 Insulin API Market Drivers
11.4.3 Insulin API Market Challenges
11.4.4 Insulin API Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Insulin API Distributors
12.3 Insulin API Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
